Stock Market
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
[ad_1]
[ad_2]
Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines that are currently in various stages of development.
Analysts led by Tazeen Ahmad reiterated their $239 price target on the stock BNTX, which is 28.5% above its current price, and said the German company’s roughly 16 billion euros in cash is a positive.
“The…
Share this news on your Fb,Twitter and Whatsapp
Times News Network:Latest News Headlines
Times News Network||Health||